Literature DB >> 2319610

Improved therapeutic index of cisplatin by procaine hydrochloride.

M Esposito1, R A Fulco, P Collecchi, A Zicca, A Cadoni, F Merlo, R Rosso, A Sobrero.   

Abstract

The local anesthetic procaine hydrochloride (P.HCl) had little effect on the sensitivity of P388 leukemic cells to cisplatin (DDP) in vitro, but the simultaneous administration of DDP and P.HCl (40 mg/kg) to BDF1 mice produced 50% lethal dose (LD50) and 90% lethal dose (LD90) values approximately two times higher than those observed with DDP alone. DDP-P.HCl diluted in water and administered intraperitoneally (IP) on day 1 and on days 1 and 5 to BDF1 mice bearing P388 leukemic cells produced 33% and 50% cure rates, respectively, at the maximum tolerated dose (16 mg/kg for the single administration and 10 mg/kg given on days 1 and 5). In contrast, under the same conditions, the cure rates obtained with DDP alone (10 mg/kg for the single administration and 8 mg/kg given on days 1 and 5) were 17% and 9%, respectively. Protection from DDP nephrotoxicity seems to be the explanation for the higher doses of DDP that mice can tolerate when DDP is given simultaneously with P.HCl. In fact, the increased blood urea nitrogen (BUN) levels observed 4-7 days following a single IP administration of DDP (8 or 16 mg/kg), as well as the tubular degenerative changes detected by light microscopy, were not observed when the same doses of DDP were given simultaneously with P.HCl. Since DDP nephrotoxicity is known to be reduced when the drug is diluted in 0.9% NaCl solution, we compared the combinations DDP-P.HCl in water, and DDP and DDP-P.HCl in 0.9% NaCl solution. The antitumor activity of DDP diluted in water and administered with P.HCl was similar to that observed in mice treated with DDP alone diluted in 0.9% NaCl solution. However, further improvement of the therapeutic index was achieved after the administration of DDP-P.HCl diluted in 0.9% NaCl solution; this regimen produced a cure rate of 67% (12 of 18 animals). The clinical relevance of these findings is strengthened by the observation that similar results were obtained when P.HCl was given by the intravenous route.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2319610     DOI: 10.1093/jnci/82.8.677

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  7 in total

1.  Procaine inhibits the proliferation and DNA methylation in human hepatoma cells.

Authors:  Motohisa Tada; Fumio Imazeki; Kenichi Fukai; Akemi Sakamoto; Makoto Arai; Rintarou Mikata; Takeshi Tokuhisa; Osamu Yokosuka
Journal:  Hepatol Int       Date:  2007-07-27       Impact factor: 6.047

2.  Protection by ebselen against cisplatin-induced nephrotoxicity: antioxidant system.

Authors:  K Husain; C Morris; C Whitworth; G L Trammell; L P Rybak; S M Somani
Journal:  Mol Cell Biochem       Date:  1998-01       Impact factor: 3.396

3.  Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration.

Authors:  D J Stewart; C Dulberg; J M Molepo; N Z Mikhael; V A Montpetit; M D Redmond; R Goel
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 4.  Direct Cytotoxic and Indirect, Immune-Mediated Effects of Local Anesthetics Against Cancer.

Authors:  Alejandra Wu Chuang; Oliver Kepp; Guido Kroemer; Lucillia Bezu
Journal:  Front Oncol       Date:  2022-01-14       Impact factor: 6.244

5.  Voltage-Gated Sodium Channels as Potential Biomarkers and Therapeutic Targets for Epithelial Ovarian Cancer.

Authors:  Iris S Brummelhuis; Stephen J Fiascone; Kathleen T Hasselblatt; Gyorgy Frendl; Kevin M Elias
Journal:  Cancers (Basel)       Date:  2021-10-29       Impact factor: 6.575

6.  Comprehensive exploration of the anticancer activities of procaine and its binding with calf thymus DNA: a multi spectroscopic and molecular modelling study.

Authors:  Mohd Sajid Ali; Mohammad Abul Farah; Hamad A Al-Lohedan; Khalid Mashay Al-Anazi
Journal:  RSC Adv       Date:  2018-03-01       Impact factor: 4.036

7.  Amide-type local anesthetics may suppress tumor cell proliferation and sensitize Human Hepatocellular Carcinoma Cells to Cisplatin via upregulation of RASSF1A expression and demethylation.

Authors:  Dongtai Chen; Yan Yan; Jingdun Xie; Jiahao Pan; Yonghua Chen; Qiang Li; Yunfei Yuan; Weian Zeng; Wei Xing
Journal:  J Cancer       Date:  2020-10-23       Impact factor: 4.207

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.